Literature DB >> 6419934

Incidence of cardiac arrhythmias in patients taking slow release salbutamol and slow release terbutaline for asthma.

A H Al-Hillawi, R Hayward, N M Johnson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6419934      PMCID: PMC1444287          DOI: 10.1136/bmj.288.6414.367

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  3 in total

1.  The frequency of asymptomatic disturbances of cardiac rhythm and conduction in middle-aged men.

Authors:  L E Hinkle; S T Carver; M Stevens
Journal:  Am J Cardiol       Date:  1969-11       Impact factor: 2.778

2.  Cardiopulmonary effects of terbutaline and a bronchodilator combination in chronic obstructive pulmonary disease.

Authors:  D J Pierson; L D Hudson; K Stark; M Hedgecock
Journal:  Chest       Date:  1980-02       Impact factor: 9.410

3.  Arrhythmogenic effects of orally administered bronchodilators.

Authors:  A S Banner; E V Sunderrajan; M K Agarwal; W W Addington
Journal:  Arch Intern Med       Date:  1979-04
  3 in total
  8 in total

1.  Comparison of the efficacy and systemic effects of 4 mg and 8 mg formulations of salbutamol controlled release in patients with asthma.

Authors:  B J Lipworth; R A Clark; D P Dhillon; J B Palmer; D G McDevitt
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Risk of non-fatal cardiac failure and ischaemic heart disease with long acting beta 2 agonists.

Authors:  R M Martin; N R Dunn; S N Freemantle; R D Mann
Journal:  Thorax       Date:  1998-07       Impact factor: 9.139

3.  Cardiac effects of salbutamol given by air driven nebuliser at home.

Authors:  J J Gilmartin; D Veale; A Murray; P C Adams; G J Gibson
Journal:  Thorax       Date:  1986-04       Impact factor: 9.139

Review 4.  Novel oral drug formulations. Their potential in modulating adverse effects.

Authors:  A T Florence; P U Jani
Journal:  Drug Saf       Date:  1994-03       Impact factor: 5.606

Review 5.  Salbutamol in the 1980s. A reappraisal of its clinical efficacy.

Authors:  A H Price; S P Clissold
Journal:  Drugs       Date:  1989-07       Impact factor: 9.546

Review 6.  The beta 2-agonist controversy. Observations, explanations and relationship to asthma epidemiology.

Authors:  M R Sears; D R Taylor
Journal:  Drug Saf       Date:  1994-10       Impact factor: 5.606

Review 7.  The epidemiology and therapy of airflow limitation in the elderly.

Authors:  L Dow
Journal:  Drugs Aging       Date:  1992 Nov-Dec       Impact factor: 3.923

Review 8.  Adverse reactions to beta 2-agonist bronchodilators.

Authors:  K M Lulich; R G Goldie; G Ryan; J W Paterson
Journal:  Med Toxicol       Date:  1986 Jul-Aug
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.